A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

PHASE4CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

December 11, 2012

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
Prostate Cancer
Interventions
DRUG

Triptorelin 11.25 mg

Triptorelin, one injection every 3 months. A total of 3 injections (at baseline, 3 and 6 months)

Trial Locations (18)

51006

SUN YAT-SEN Cancer Center Department of Site #156009, Guangzhou

100853

Chinese PLA General HospitalDepartment of UrologySite #156007, Beijing

105425

"FSBI Research Institute of Urology of Ministry of health care of Russia Site #643002", Moscow

111123

"State Budgetary Healthcare Institution Moscow Clinical Scientific-Practical Center named after A. S. Loginov of Healthcare Department of Moscow Site #643009", Moscow

115478

FSBI Russian Oncological Scientific Center named after N.N. Blokhina of RAMS, 23 Site #643001, Moscow

117593

"Federal State Budgetary Health care Institution Central clinical hospital of Russian Academy of Science (CCH RAS), in-patient unit, urological department Site #643005", Moscow

125284

FSI Moscow Research Oncological Institute named after P.A.Gertsen Site #643003, Moscow

249036

"Medical radiology research center named after A.F. Tsyba - branch of FSBI National Medical Research Center of Radiology of Ministry of healthcare of Russian Federation Site #643008", Obninsk

610041

West China Hosspital, Sichuan UniversityDepartment of Urology Site #156008, Chengdu

620102

SBHI Sverdlovskaya Regional Clinical Hospital #1 Site #643004, Yekaterinburg

644013

"Budgetary Health care Institution of Omsk region Clinical oncological dispensary Site #643007", Omsk

656052

SIH Altaian Territorial Oncological Dispensary Site #643006, Barnaul

Unknown

Peiking University First Hospital Site #156011, Beijing

The First Affiliated Hospital of the 3th Military Medical University of PLA (Southwest Hospital) Site # 156010, Chongqing

The third hospital affiliated to Sun Yat-sen University Site #156005, Guangzhou

The first hospital affiliated to medical school of Zhejiang university Site #156001, Hangzhou

Fudan University cancer hospital Site #156003, Shanghai

First Affiliated Hospital of the Fourth Military Medical University Site #156004, Xi'an

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT01753297 - A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. | Biotech Hunter | Biotech Hunter